Clinical Trial Update: Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tenofovir alone versus tenofovir with emtricitabine for chronic hepatitis B; study terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Tenofovir (Tenofovir)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis B | Phase 2 | Status: TERMINATED | Results posted: 2018-04-18